• @[email protected]
    link
    fedilink
    English
    626 months ago

    Interesting, but that headline is misleading.

    A single patient was weaned off blood sugar medication over a year and hasn’t redeveloped diabetes in almost three years.

    There’s obviously a lot more research into the cell therapy process and many more patients are going to have to undergo this therapy in controlled conditions before we can call it a new cure.

    Right now, this is an interesting medical anomaly that occurred over more than a year of treatment in which someone’s pancreatic process was restored in correlation with a new cell therapy.

    • @[email protected]OP
      link
      fedilink
      English
      46 months ago

      First human trial for a treatment strategy passed (notably, we know that placebo treatments for diabetes fail). This more than passes the bar to justify further large-scale human trials and, clinically, is a very strong indicator of success.

      What, is it not a cure until it’s available to the public?

      • @[email protected]
        link
        fedilink
        English
        166 months ago

        It justifies, in fact begs for human trials, but a single unregulated data point from a single moment is hardly a cure.

        It becomes a cure after the treatment is isolated from mitigating factors and acutely applied to the same disorder in many patients in controlled conditions with peer-reviewed and independently confirmed repeatable results over time.

      • @ReallyActuallyFrankenstein
        link
        English
        86 months ago

        Well, the phrase is, “the plural of anecdote is not statistic.” In this case, we only have a single case, so it doesn’t even escape “anecdote.” I think at that point, there isn’t yet a scientific basis to call it a “cure.”